Results 91 to 100 of about 80,391,203 (292)
Type 2 diabetes mellitus (T2DM), obesity, and metabolic dysfunction‐associated steatotic liver disease (MASLD) are epidemiologically correlated disorders with a worldwide growing prevalence.
A. Aizenshtadt +14 more
semanticscholar +1 more source
Osimertinib is effective against EGFR‐mutant NSCLC, but resistance often develops. We found that increased cholesterol in lipid rafts, specialized regions of the cell membrane, promotes recruitment of the scaffold protein FLOT1 and insulin receptors.
Yen‐Lin Lai +2 more
wiley +1 more source
In the last few years, considerable attention has been given to in vitro models in an attempt to reduce the use of animals and to decrease the rate of preclinical failure associated with the development of new drugs. Simple two-dimensional cultures grown in a dish are now frequently replaced by organotypic cultures with three-dimensional (3-D ...
David Bovard +4 more
openaire +1 more source
The translational roadmap of the gut models, focusing on gut-on-chip
It is difficult to model in vitro the intestine when seeking to include crosstalk with the gut microbiota, immune and neuroendocrine systems.
Giulia Malaguarnera +2 more
doaj +1 more source
DigiLoCS: A leap forward in predictive organ-on-chip simulations
Digital twins, driven by data and mathematical modelling, have emerged as powerful tools for simulating complex biological systems. In this work, we focus on modelling the clearance on a liver-on-chip as a digital twin that closely mimics the clearance ...
M. Aravindakshan +4 more
semanticscholar +1 more source
Mechanical Stimulation: A Crucial Element of Organ-on-Chip Models
Organ-on-chip (OOC) systems recapitulate key biological processes and responses in vitro exhibited by cells, tissues, and organs in vivo. Accordingly, these models of both health and disease hold great promise for improving fundamental research, drug ...
C. Thompson +4 more
semanticscholar +1 more source
Applications of Polymers for Organ-on-Chip Technology in Urology
Organ-on-chips (OOCs) are microfluidic devices used for creating physiological organ biomimetic systems. OOC technology brings numerous advantages in the current landscape of preclinical models, capable of recapitulating the multicellular assemblage ...
B. Gălățeanu +8 more
semanticscholar +1 more source
NMR metabolomics revealed concentration‐dependent metabolic perturbations in HepG2 cells exposed to H2O2. Rifampicin pretreatment enhanced metabolic competence, attenuated toxin‐induced alterations and produced metabolite profiles more consistent with human liver physiology, supporting the use of CYP450‐induced HepG2 models for improved in vitro ...
Maren Jinks +4 more
wiley +1 more source
Traditional toxicology, with its reliance on animal models and oversimplified cell cultures, often fails to predict human responses due to interspecies differences and limited physiological relevance. Organ-on-a-chip (OoC) technology, as a microengineering breakthrough, enables reconstruction of human-relevant organ functions, providing a powerful tool
Sheng Yang +9 more
openaire +3 more sources
Organs-on-chips: a decade of innovation
Recreating 'living organs' with groundbreaking organ-on-a-chip (OOC) technologies is facilitating a new era of drug discovery. Studies by Huh et al. and Ronaldson-Bouchard et al. underscore advances made over a decade, spanning single organ functionality to interconnected organs, that enable examination of drug toxicities and disease pathogenesis in ...
Carly Strelez +2 more
openaire +2 more sources

